Recently, positive CV outcomes and reduced hospitalization for heart failure (HF) were noted in patients with HF with reduced ejection fraction (HFrEF) treated with novel emerging agents. Cardiologists struggle to stay current with the latest advances in HF, including novel emerging agents. In this 4-part podcast series, expert clinicians discuss the mechanism of action, clinical trial data, and potential use of soluble guanylate cyclase (sGC) inhibitors in patients with HFrEF.

The Clinical Evidence: Efficacy and Safety of sGC Modulators in Heart Failure With Reduced Ejection Fraction With Drs. Paul Armstrong and Javed Butler

The Clinical Evidence: Efficacy and Safety of sGC Modulators in Heart Failure With Reduced Ejection Fraction With Drs. Paul Armstrong and Javed Butler

In this podcast, expert clinicians will discuss the safety and efficacy of…

Expiration Date: 12/27/2021

Max Credits: 0.25

View Activity

sGC Modulators: Unique Mechanism of Action and Rationale for Use in Heart Failure With Drs. Paul Armstrong and Carolyn Lam

sGC Modulators: Unique Mechanism of Action and Rationale for Use in Heart Failure With Drs. Paul Armstrong and Carolyn Lam

In this podcast, expert clinicians will discuss the mechanism of action of…

Expiration Date: 12/27/2021

Max Credits: 0.25

View Activity

sGC Modulators: Role in Current Treatment Paradigms for Heart Failure With Drs. Paul Armstrong and Javed Butler

sGC Modulators: Role in Current Treatment Paradigms for Heart Failure With Drs. Paul Armstrong and Javed Butler

In this podcast, expert clinicians will discuss the potential use of sGC m…

Expiration Date: 12/27/2021

Max Credits: 0.25

View Activity

Heart Failure Management: Guideline-directed Therapy and Unmet Needs With Drs. Paul Armstrong and Carolyn Lam

Heart Failure Management: Guideline-directed Therapy and Unmet Needs With Drs. Paul Armstrong and Carolyn Lam

In this podcast, expert clinicians will discuss the burden of heart failur…

Expiration Date: 12/27/2021

Max Credits: 0.25

View Activity